Antibodies, Monoclonal, Humanized
DBCAT000014Pharmacologic class
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. A DrugBank category of 194 drugs. 83 of them are approved.
- Part of
- Antibodies, Monoclonal
- Also known as
- Antibodies, Humanized · Humanized Antibodies · Humanized monoclonal antibodies
- Drugs
- Abciximab
- Abituzumab
- Adalimumab
- Alemtuzumab
- Anrukinzumab
- Apolizumab
- Atezolizumab
- Atoltivimab
- Bamlanivimab
- Bapineuzumab
- Basiliximab
- Belantamab mafodotin
- Bemarituzumab
- Benralizumab
- Bevacizumab
- Bevacizumab zirconium Zr-89
- Bimekizumab
- Bivatuzumab
- Blosozumab
- Bococizumab
- Brentuximab vedotin
- Brolucizumab
- Brontictuzumab
- Cabiralizumab
- Camrelizumab
What you can answer from here — as of April 20, 2021
Which targets do Antibodies, Monoclonal, Humanized share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account